Literature DB >> 12270178

Structure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor.

Venkata P Palle1, Elfatih O Elzein, Scott A Gothe, Zhihe Li, Zhenhai Gao, Stephanie Meyer, Brent Blackburn, Jeff A Zablocki.   

Abstract

The structure-affinity relationships of two novel 2-substituted adenosine series containing a substituted pyrazole attached at the N-1 or C-4 position for the adenosine (ADO) A2A receptor are described. Compounds in the 2-(N-1-pyrazolyl) adenosine series IV provided the highest affinity for the ADO A2A receptor as compared to the 2-(C-4-pyrazolyl) series V. The main structural differences between the two series point to the N-1 nitrogen of series IV imparting more favorable binding interactions with the receptor than those of series V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270178     DOI: 10.1016/s0960-894x(02)00609-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

Review 1.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

2.  Is regadenoson an appropriate stressor for MPI in patients with left bundle branch block or pacemakers?

Authors:  Gregory S Thomas; Carissa R Kinser; Rita Kristy; Jiaqiong Xu; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2013-10-17       Impact factor: 5.952

3.  Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma Model.

Authors:  Amélie Vézina; Monica Manglani; DreeAnna Morris; Brandon Foster; Matthew McCord; Hua Song; Meili Zhang; Dionne Davis; Wei Zhang; Jessica Bills; Kunio Nagashima; Priya Shankarappa; Jessica Kindrick; Stuart Walbridge; Cody J Peer; William D Figg; Mark R Gilbert; Dorian B McGavern; Leslie L Muldoon; Sadhana Jackson
Journal:  Mol Cancer Res       Date:  2021-09-14       Impact factor: 6.333

4.  1,2,3-Triazoles as leaving groups: SNAr reactions of 2,6-bistriazolylpurines with O- and C-nucleophiles.

Authors:  Dace Cīrule; Irina Novosjolova; Ērika Bizdēna; Māris Turks
Journal:  Beilstein J Org Chem       Date:  2021-02-11       Impact factor: 2.883

Review 5.  Carbohydrate-based drugs launched during 2000-2021.

Authors:  Xin Cao; Xiaojing Du; Heng Jiao; Quanlin An; Ruoxue Chen; Pengfei Fang; Jing Wang; Biao Yu
Journal:  Acta Pharm Sin B       Date:  2022-05-23       Impact factor: 14.903

Review 6.  Regadenoson in the detection of coronary artery disease.

Authors:  Christiane Buhr; Mario Gössl; Raimund Erbel; Holger Eggebrecht
Journal:  Vasc Health Risk Manag       Date:  2008

7.  Adenosine Receptor Agonists Exhibit Anti-Platelet Effects and the Potential to Overcome Resistance to P2Y12 Receptor Antagonists.

Authors:  Nina Wolska; Magdalena Boncler; Dawid Polak; Joanna Wzorek; Tomasz Przygodzki; Magdalena Gapinska; Cezary Watala; Marcin Rozalski
Journal:  Molecules       Date:  2019-12-28       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.